Tumor-targeted liposomes: Doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

Journal of Controlled Release

Volumn 100, Issue 1, 2004, Pages 135-144

  Lukyanov, Anatoly N ^a   Elbayoumi, Tamer A ^a   Chakilam, Ananthsrinivas R ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Anticancer antibody; Doxorubicin; Immunoliposomes; Long circulating liposomes; Tumor targeting

Indexed keywords

LIPOSOMES; NUCLEOSOMES; PROTEIN MOLECULES;

ANTIBODIES; CELLS; DRUG PRODUCTS; POLYETHYLENE GLYCOLS; PROTEINS; TUMORS;

ONCOLOGY;

CANCER ANTIBODY; CARBONYL DERIVATIVE; DOXORUBICIN; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2C5; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL SURFACE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG TARGETING; ENCAPSULATION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOSOME; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CELL LINE, TUMOR; DOXORUBICIN; HUMANS; LIPOSOMES; MICE; NEOPLASMS; NUCLEOSOMES;

EID: 7444236397     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.08.007     Document Type: Article

References (33)

1. D. Lasic F. Martin Stealth Liposomes 1995 CRC Press Boca Raton
2. V.P. Torchilin, and V.S. Trubetskoy Which polymers can make nanoparticulate drug carriers long-circulating? Adv. Drug Deliv. Rev. 16 1995 141 155
3. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1 1990 235 237
4. G. Blume, and G. Cevc Molecular mechanism of the lipid vesicle longevity in vivo Biochim. Biophys. Acta 1146 2 1993 157 168
5. J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles Biochim. Biophys. Acta 1062 1 1991 77 82
6. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 12 Pt. 1 1986 6387 6392
7. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
8. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, V.P. Torchilin, and R.K. Jain Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 55 17 1995 3752 3756
9. A.A. Gabizon Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy Cancer Investig. 19 4 2001 424 436
10. O. Lyass, B. Uziely, R. Ben-Yosef, D. Tzemach, N.I. Heshing, M. Lotem, G. Brufman, and A. Gabizon Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma Cancer 89 5 2000 1037 1047
11. 2 Ann. Oncol. 11 8 2000 1029 1033
12. K.M. Skubitz Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma Cancer Investig. 21 2 2003 167 176
13. R.J. Lee, and P.S. Low Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro Biochim. Biophys. Acta 1233 2 1995 134 144
14. D. Goren, A.T. Horowitz, D. Tzemach, M. Tarshish, S. Zalipsky, and A. Gabizon Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump Clin. Cancer Res. 6 5 2000 1949 1957
15. J.N. Moreira, C.B. Hansen, R. Gaspar, and T.M. Allen A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer Biochim. Biophys. Acta 1514 2 2001 303 317
16. J.W. Park, D.B. Kirpotin, K. Hong, R. Shalaby, Y. Shao, U.B. Nielsen, J.D. Marks, D. Papahadjopoulos, and C.C. Benz Tumor targeting using anti-her2 immunoliposomes J. Control. Release 74 1-3 2001 95 113
17. L.Z. Iakoubov, O. Rokhlin, and V.P. Torchilin Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells Immunol. Lett. 47 1-2 1995 147 149
18. L.Z. Iakoubov, and V.P. Torchilin A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice Oncol. Res. 9 8 1997 439 446
19. L.Z. Iakoubov, and V.P. Torchilin Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies Cancer Detect. Prev. 22 5 1998 470 475
20. V.P. Torchilin, T.S. Levchenko, A.N. Lukyanov, B.A. Khaw, A.L. Klibanov, R. Rammohan, G.P. Samokhin, and K.R. Whiteman p-Nitrophenylcarbonyl-PEG-PE- liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups Biochim. Biophys. Acta 1511 2 2001 397 411
21. A. Lorenzen, and S.W. Kennedy A fluorescence-based protein assay for use with a microplate reader Anal. Biochem. 214 1 1993 346 348
22. J.M. Saul, A. Annapragada, J.V. Natarajan, and R.V. Bellamkonda Controlled targeting of liposomal doxorubicin via the folate receptor in vitro J. Control. Release 92 1-2 2003 49 67
23. R.P. Haugland Coupling of monoclonal antibodies with fluorophores Methods Mol. Biol. 45 1995 205 221
24. V.P. Torchilin, A.N. Lukyanov, Z. Gao, and B. Papahadjopoulos-Sternberg Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs Proc. Natl. Acad. Sci. U. S. A. 100 10 2003 6039 6044
25. T.M. Allen, P. Sapra, and E. Moase Use of the post-insertion method for the formation of ligand-coupled liposomes Cell. Mol. Biol. Lett. 7 3 2002 889 894
26. B.W. Liang, T.S. Levchenko, B.A. Khaw, and V.P. Torchilin ATP-containing immunoliposomes specific for cardiac myosin Curr. Drug Deliv. 1 1 2004 1 7
27. K. Sou, T. Endo, S. Takeoka, and E. Tsuchida Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles Bioconjug. Chem. 11 3 2000 372 379
28. T. Ishida, D.L. Iden, and T.M. Allen A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs FEBS Lett. 460 1 1999 129 133
29. J.N. Moreira, T. Ishida, R. Gaspar, and T.M. Allen Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity Pharm. Res. 19 3 2002 265 269
30. A.L. Klibanov, V.R. Muzykantov, N.N. Ivanov, and V.P. Torchilin Evaluation of quantitative parameters of the interaction of antibody-bearing liposomes with target antigens Anal. Biochem. 150 2 1985 251 257
31. D.A. Bell, and B. Morrison The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro Clin. Immunol. Immunopathol. 60 1 1991 13 26
32. L. Jacob, J.P. Viard, B. Allenet, M.F. Anin, F.B. Slama, J. Vandekerckhove, J. Primo, J. Markovits, F. Jacob, and J.F. Bach A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex Proc. Natl. Acad. Sci. U. S. A. 86 12 1989 4669 4673
33. S. Koutouzov, A. Cabrespines, Z. Amoura, H. Chabre, C. Lotton, and J.F. Bach Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies Eur. J. Immunol. 26 2 1996 472 486